We have located links that may give you full text access.
Does lower urine-specific gravity predict decline in renal function and hypernatremia in older adults exposed to psychotropic medications? An exploratory analysis.
Clinical Kidney Journal 2016 April
BACKGROUND: Exposure to psychotropic agents, including lithium, antipsychotics and antidepressants, has been associated with nephrogenic diabetes insipidus (NDI). This is especially concerning in older adults already at risk of developing chronic kidney disease (CKD) and hypernatremia with advanced aging. This study investigates whether commonly performed random urine-specific gravity (USG) tests can predict adverse NDI outcomes (CKD and hypernatremia) in psychotropic-exposed older adults.
METHODS: This was a retrospective longitudinal study of 173 geriatric psychiatry patients (age ≥65 years) exposed to psychotropic medications. Our main continuous outcome was 'decrease in estimated glomerular filtration rate (eGFR) >10 mL/min/1.73 m(2)' over 5-year follow-up. Hypernatremia and acute kidney injury (AKI) were secondary outcomes. Whether baseline USG <1.010 predicted outcomes was assessed in bivariate and multivariate analyses.
RESULTS: USG <1.010 predicted hypernatremia episodes (sodium concentration ≥150 mmol/L-28.1 versus 12%, χ(2) = 4.7, P = 0.03). USG <1.010 [odds ratio 2.36 (95% confidence interval 0.93-6.0), P = 0.07], baseline eGFR and typical antipsychotic use independently predicted decrease in eGFR >10 mL/min/1.73 m(2). Patients with a single baseline sodium concentration of ≥140 mmol/L and USG <1.010 have a 26.3% incidence of AKI and a 57.9% incidence of hypernatremia over the ensuing 5 years.
CONCLUSIONS: In psychotropic-exposed older adults, there appears to be a clinically important association between low USG and developing both hypernatremia and CKD. USG may be a useful surrogate measure for NDI-related outcomes in large administrative database studies, where ideal measures such as 24-h urine volume may not be available.
METHODS: This was a retrospective longitudinal study of 173 geriatric psychiatry patients (age ≥65 years) exposed to psychotropic medications. Our main continuous outcome was 'decrease in estimated glomerular filtration rate (eGFR) >10 mL/min/1.73 m(2)' over 5-year follow-up. Hypernatremia and acute kidney injury (AKI) were secondary outcomes. Whether baseline USG <1.010 predicted outcomes was assessed in bivariate and multivariate analyses.
RESULTS: USG <1.010 predicted hypernatremia episodes (sodium concentration ≥150 mmol/L-28.1 versus 12%, χ(2) = 4.7, P = 0.03). USG <1.010 [odds ratio 2.36 (95% confidence interval 0.93-6.0), P = 0.07], baseline eGFR and typical antipsychotic use independently predicted decrease in eGFR >10 mL/min/1.73 m(2). Patients with a single baseline sodium concentration of ≥140 mmol/L and USG <1.010 have a 26.3% incidence of AKI and a 57.9% incidence of hypernatremia over the ensuing 5 years.
CONCLUSIONS: In psychotropic-exposed older adults, there appears to be a clinically important association between low USG and developing both hypernatremia and CKD. USG may be a useful surrogate measure for NDI-related outcomes in large administrative database studies, where ideal measures such as 24-h urine volume may not be available.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app